Putting GlaxoSmithKline to the test over paroxetine.
BMJ, London WC1H 9JR, UK.
Peter
P
Doshi
D022126:Access to Information / Q000331:legislation & jurisprudence; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000331:legislation & jurisprudence; D006801:Humans; D017374:Paroxetine / Q000009:adverse effects* / Q000627:therapeutic use; D006113:United Kingdom; D014481:United States
D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine